Ketogenic diets and pain

Journal of Child Neurology

Volumn 28, Issue 8, 2013, Pages 993-1001

  Masino, Susan A ^a   Ruskin, David N ^a  

^a TRINITY COLLEGE   (United States)

Author keywords

chronic constriction injury; glucose; hypoalgesia; inflammation; ketones; metabolismc; neuropathic pain; Taxol

Indexed keywords

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; CHRONIC PAIN; COMORBIDITY; CONFERENCE PAPER; HUMAN; HYPOALGESIA; INFLAMMATION; KETOGENIC DIET; NEUROPATHIC PAIN; NONHUMAN; PAIN; PRIORITY JOURNAL; THERMAL PAIN;

EID: 84880842042     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813487595     Document Type: Conference Paper

References (68)

1. Elliott AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the community. Lancet. 1999 ; 354: 1248-1252
2. Becker N, Bondegaard-Thomsen A, Olsen AK, et al. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain. 1997 ; 73: 393-400
3. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization study in primary care. J Am Med Assoc. 1998 ; 280: 147-151
4. Wilder RM. The effects of ketonemia on the course of epilepsy. Mayo Clin Bull. 1921 ; 2: 307
5. Wilder RM. High fat diets in epilepsy. Mayo Clin Bull. 1921 ; 2: 308
6. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983 ; 306: 686-688
7. Raja SN, Meyer RA, Campbell JN. Peripheral mechanisms of somatic pain. Anesthesiology. 1988 ; 68: 571-590
8. Stafstrom CE, Ockuly JC, Murphree L, et al. Anticonvulsant and antiepileptic actions of 2-deoxy-d-glucose in epilepsy models. Ann Neurol. 2009 ; 65: 435-447
9. Fisher MC, Bodnar RJ.. 2-Deoxy-d-glucose antinociception and serotonin receptor subtype antagonists: test-specific effects in rats. Pharmacol Biochem Behav. 1992 ; 43: 1241-1246
10. de los Santos-Arteaga M, Sierra-Domínguez SA, Fontanella GH, et al. Analgesia induced by dietary restriction is mediated by the κ-opioid system. J Neurosci. 2003 ; 23: 11120-11126
11. Yarbrough GG, McGuffin-Clineschmidt JC.. In vivo behavioral assessment of central nervous system purinergic receptors. Eur J Pharmacol. 1981 ; 76: 137-144
12. Schmidt AP, Böhmer AE, Antunes C, et al. Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol. 2009 ; 156: 163-172
13. Goldman N, Chen M, Fujita T, et al. Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture. Nat Neurosci. 2010 ; 13: 883-888
14. Takano T, Chen X, Luo F, et al. Traditional acupuncture triggers a local increase in adenosine in human subjects. J Pain. 2012 ; 13: 1215-1223
15. Zhao YT, Tekkök S, Krnjević K.. 2-Deoxy-d-glucose-induced changes in membrane potential, input resistance, and excitatory postsynaptic potentials of CA1 hippocampal neurons. Can J Physiol Pharmacol. 1997 ; 75: 368-374
16. Minor TR, Rowe MK, Soames-Job RF, Ferguson EC. Escape deficits induced by inescapable shock and metabolic stress are reversed by adenosine receptor antagonists. Behav Brain Res. 2001 ; 120: 203-212
17. Kawamura M, Ruskin DN, Masino SA. Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors and KATP channels. J Neurosci. 2010 ; 30: 3886-3895
18. Jinka TR, Carlson ZA, Moore JT, Drew KL. Altered thermoregulation via sensitization of A1 adenosine receptors in dietary-restricted rats. Psychopharmacology. 2010 ; 209: 217-224
19. Masino SA, Li T, Theofilas P, et al. A ketogenic diet suppresses seizures in mice through adenosine A1 receptors. J Clin Invest. 2011 ; 121: 2679-2683
20. Martins DF, Mazzardo-Martins L, Soldi F, et al. High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system. Neuroscience. 2013 ; 234: 69-76
21. Ruskin DN, Masino SA. The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy. Front Neurosci. 2012 ; 6: 33
22. Ruskin DN, Kawamura M, Masino SA. Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One. 2009 ; 4: e8349
23. Ruskin DN, Suter TACS, Ross JL, Masino SA.. Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats. J Pain. 2013 ;: S1526 00023-5900 0
24. Ruskin DN, Ross JL, Kawamura M, et al. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1 J mouse model of Huntington's disease. Physiol Behav. 2011 ; 103: 501-507
25. Ziegler DR, Gamaro GD, Araújo E, et al. Nociception and locomotor activity are increased in ketogenic diet fed rats. Physiol Behav. 2005 ; 84: 421-427
26. Likhodii SS, Musa K, Mendonca A, et al. Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia. 2000 ; 41: 1400-1410
27. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids. 2004 ; 70: 309-319
28. Kim DY, Davis LM, Sullivan PG, et al. Ketone bodies are protective against oxidative stress in neocortical neurons. J Neurochem. 2007 ; 101: 1316-1326
29. Kim DY, Vallejo J, Rho JM. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J Neurochem. 2010 ; 114: 130-141
30. Noh HS, Hah Y-S, Nilufar R, et al. Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J Neurosci Res. 2006 ; 83: 702-709
31. Maalouf M, Rho JM. Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J Neurosci Res. 2008 ; 86: 3322-3330
32. Maalouf M, Sullivan PG, Davis L, et al. Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience. 2007 ; 145: 256-264
33. Haces ML, Hernandez-Fonseca K, Medina-Campos ON, et al. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp Neurol. 2008 ; 211: 85-96
34. Sullivan PG, Rippy NA, Dorenbos K, et al. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann Neurol. 2004 ; 55: 576-580
35. Kim DY, Hao J, Liu R, et al. Inflammation-mediated memory dysfunction and effects of a ketogenic diet in a murine model of multiple sclerosis. PLoS One. 2012 ; 7: e35476
36. Tendler D, Lin S, Yancy WS, et al. The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci. 2007 ; 52: 589-593
37. Pérez-Guisado J, Muñoz-Serrano A. The effect of the Spanish Ketogenic Mediterranean Diet on nonalcoholic fatty liver disease: a pilot study. J Med Food. 2011 ; 14: 677-680
38. Schugar RC, Crawford PA. Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012 ; 15: 374-380
39. Michalik L, Auwerx J, Berger JP, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev. 2006 ; 58: 726-741
40. Cuzzocrea S, Pisano B, Dugo L, et al. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation. Eur J Pharmacol. 2004 ; 483: 79-93
41. Cuzzocrea S, Mazzon E, Dugo L, et al. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum. 2003 ; 48: 3544-3556
42. LoVerme J, Fu J, Astarita G, et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol. 2005 ; 67: 15-19
43. Cuzzocrea S, Mazzon E, Di Paolo R, et al. The role of the peroxisome proliferator-activated receptor-α (PPAR-α) in the regulation of acute inflammation. J Leukoc Biol. 2006 ; 79: 999-1010
44. Blanquart C, Barbier O, Fruchart JC, et al. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol. 2003 ; 85: 267-273
45. Kowaluk EA, Jarvis MF. Therapeutic potential of adenosine kinase inhibitors. Expert Opin Investig Drugs. 2000 ; 9: 551-564
46. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Ann Rev Pharmacol Toxicol. 2001 ; 41: 775-787
47. Ngamsri K-C, Wagner R, Vollmer I, et al. Adenosine receptor A1 regulates polymorphonuclear cell trafficking and microvascular permeability in lipopolysaccharide-induced lung injury. J Immunol. 2010 ; 185: 4374-4384
48. Wang J, Huxley VH. Adenosine A2A receptor modulation of juvenile female rat skeletal muscle microvessel permeability. Am J Physiol Heart Circ Physiol. 2006 ; 291: H3094 - H3105
49. Sorkin LS, Moore J, Boyle DL, et al. Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp Neurol. 2003 ; 184: 162-168
50. Campbell JN, Meyer RA. Mechanisms of neuropathic pain. Neuron. 2006 ; 52: 77-92
51. Portenoy RK, Foley KM, Inturrisi CE. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 1990 ; 43: 273-286
52. Dickenson AH, Suzuki R. Opioids in neuropathic pain: clues from animal studies. Eur J Pain. 2005 ; 9: 113-116
53. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988 ; 33: 87-107
54. Uhlemann ER, Neims AH. Anticonvulsant properties of the ketogenic diet in mice. J Pharmacol Exp Ther. 1972 ; 180: 231-238
55. Samala R, Willis S, Borges K. Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models. Epilepsy Res. 2008 ; 81: 119-127
56. Hartman AL, Zheng X, Bergbower E, et al. Seizure tests distinguish intermittent fasting from the ketogenic diet. Epilepsia. 2010 ; 51: 1395-1402
57. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc. Natl Acad Sci U S A. 2013 ; 110: 3507-3512
58. Rho JM, Zupec-Kania B, Masino SA Adenosine: A Key Link Between Metabolism and Brain Activity. Masino SA Boison D, ed. New York: Springer ; 2013 :
59. Phillips CJ. Economic burden of chronic pain. Expert Rev Pharmacoecon Outcomes Res. 2006 ; 6: 591-601
60. Morrison PF, Pyzik PL, Hamdy R, et al. The influence of concurrent anticonvulsants on the efficacy of the ketogenic diet. Epilepsia. 2009 ; 50: 1999-2001
61. Poplawski MM, Mastaitis JW, Isoda F, et al. Reversal of diabetic nephropathy by a ketogenic diet. PLoS One. 2011 ; 6: e18604
62. Atladottir HO, Thorsen P, Schendel DE, et al. Association of hospitalization for infection in childhood with diagnosis of autism spectrum disorders: a Danish cohort study. Arch Pediatr Adolesc Med. 2010 ; 164: 470-477
63. Canitano R. Epilepsy in autism spectrum disorders. Eur Child Adolesc Psychiatry. 2007 ; 16: 61-66
64. Heneka MT, O'Banion MK. Inflammatory processes in Alzheimer's disease. J Neuroimmunol. 2007 ; 184: 69-91
65. Pandis D, Scarmeas N. Seizures in Alzheimer disease: clinical and epidemiological data. Epilepsy Curr. 2012 ; 12: 184-187
66. Cai H, Cong WN, Ji S, et al. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr Alzheimer Res. 2012 ; 9: 5-17
67. Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol. 2012 ; 3: 59
68. Yau PL, Castro MG, Tagani A, et al. Obesity and metabolic syndrome and functional and structural brain impairments in adolescence. Pediatrics. 2012 ; 130: e856 - e864